Nueterra Capital portfolio company Casetabs announced today that they have received $3 million in financing to accelerate growth and expand physician practice and partner integration capabilities. You can read more in Business Wire.
More than 150 investors, civic leaders and entrepreneur applicants packed the eighth-floor club lounge of Two Light Luxury Apartments in Downtown Kansas City, Missouri on Tuesday night to kick off the LaunchKC Health Accelerator powered by Nueterra Capital.
After introductory remarks from Kansas City Mayor-Elect Quinton Lucas, Nueterra Capital CEO Jeremy Tasset welcomed the crowd and explained why the firm decided to partner with LaunchKC on the Launch Health Accelerator. “There is a huge problem with the healthcare system as we know it today,” said Tasset. “Policy might help, but what’s going to solve the problem is innovation – the kind of innovation that the Launch Health Accelerator helps foster. We want to be part of that innovation solution.”
Focusing on early and growth-stage healthcare companies, Nueterra Capital invests in companies in the business of providing patient care, services that enable communication between providers and patients or employers and employees, and technology, including software, applications, and devices.
Through the Launch Health Accelerator, Nueterra Capital hopes to attract companies sparking payment reform through transparent pricing and quality metrics, facilitating risk transfer from payors and employers to providers and patients, and using data to analyze behavior, decision-making and pricing.
“The support of LaunchKC and the City of Kansas City has been incredible,” said Tasset. “We’re excited to be a part of this and help make change.”
Don Peterson, a health care industry veteran who founded disruptor Infusion Express, will serve as the Launch Health Accelerator’s Entrepreneur in Residence. Peterson told the crowd that having worked with Nueterra Capital for many years, their proven record in healthcare innovation made them the right partner for the Launch Health Accelerator.
Applications for the Launch Health Accelerator are being accepted now through August 15.
Infusion Express recently announced they will be expanding their patient-focused alternative to hospital-based infusion centers into three new markets in the Philadelphia area. The Malvern, PA infusion center offers infusion therapy and injections for a wide range of pharmaceutical drugs. Infusion and IV therapy centers will open in Bensalem, PA the week of May 13 and in Montgomeryville, PA later this summer. You can read the full press release here.
We want to congratulate HealthJoy on their Series B round of funding. HealthJoy uses artificial intelligence to help employees navigate their healthcare benefit options, and we’re proud to have been part of the Series A round. You can read more about the Series B round on TechCrunch and Built in Chicago.
We’re proud that our investment in Casetabs helped create a cloud-based surgery coordination platform for surgery centers, hospitals, physician offices and medical device companies for real-time medical updates, scheduling and alerts. You can read more about the latest fundraising round in the Los Angeles Business Journal.
Orlando, FL (December 21, 2018) – CAREstream America, a premier product and services distributor for pain management, regenerative and aesthetic specialties, announces the acquisition of Catalyst Sales & Marketing, a regenerative medicine solutions provider based in Houston, TX. Effective December 21, 2018, this acquisition significantly expands CAREstream America’s product portfolio and related offerings to its customers, particularly those focused on regenerative medicine.
CAREstream America plans to merge Catalyst’s comprehensive regenerative medicine portfolio with its existing product lines and revolutionize its vast physician support network under another newly acquired endeavor called Axiom Therapies. The transition to CAREstream America’s corporate office in Altamonte Springs, FL is to be determined.
Catalyst CEO, Bill Cramer remarked, “This is a pivotal moment for the regenerative landscape and this opportunity establishes our position at the forefront of this advancing healthcare evolution.”
CAREstream America acquired majority ownership of Axiom Therapies, formerly a wholly-owned subsidiary of Nueterra Capital, on November 30, 2018. Axiom Therapies empowers clinicians to provide next-generation, cell-enhanced treatments founded on the principles of evidence-based regenerative medicine. Axiom Therapies will focus on Orthopedics, Pain and Rheumatology, with a full complement of regenerative therapy solutions including: APIC-A2M, PRP, PRFM, Exosomes, Amniotic Fluid, Bone Marrow- and Adipose-Derived Stem Cell Therapies, and VitalityRED for ED.
The enhanced Axiom Therapies will be led by President, Blake Petrunick, with most of the senior leadership from Catalyst joining him. “We are focused in the MSK space with an extensive roster of Regenerative Therapy solutions to bring solid, proven clinical outcomes to this evolving healthcare market,” commented Mr. Petrunick.
Regarding the industry-shaping merger, Chairman of the Board, Dr. Allen Sperry said, “documenting clinical outcomes of our therapies to ensure the optimum therapeutic regimen and protocols is our mandate.” He further mentioned, “Blake Petrunick, Bill Cramer, Jordan Jozwick and Brandon Cusick are as experienced and knowledgeable as any leadership team in this business today.”
This transformational merger will create pathways for accelerated growth, while ensuring FDA compliance with premium products and outcome measurements to make Axiom Therapies the leader in regenerative medicine in the MSK world.
About CAREstream America
CAREstream America is a division of CAREstream Medical Ltd, which has been serving customer’s respiratory and anesthesia needs for over 20 years. CAREstream America began in 2013 and distributes; pain management and aesthetic products from helping to shape and image the body to relieving the pain and anxiety of procedures. CAREstream America carry human med, Whale Imaging, Chemometec, Christie Medical and CMI – ranging from water-jet assisted technology to cell counting, ultrasound and vascular access imaging to nitrous oxide analgesia. With the Gentec and Westmed product lines offering a variety of medical products for patient care from suction products, adaptors, flowmeters and regulators to anesthesia, respiratory and critical care. Visit www.carestreamamerica.com for more.
About Nueterra Capital
Nueterra Capital is a healthcare-focused private equity firm that invests in companies on the leading edge of healthcare reform. Nueterra Capital invests in healthcare providers, services, and technology companies whose business model reshapes the healthcare industry through advanced payment methods, innovative risk transfer models, data analysis, and advocating patient consumerism. Nueterra Capital has offices in Leawood, KS and Nashville, TN. To learn more, visit www.nueterra.com.
We’re proud that our investment in Casetabs helped create an expanded platform that includes patient engagement. You can read more about this important development in Casetabs’ press release.
Hosted by Travis Tasset, the Value Talks podcast explores a range of topics that matter to people, including healthcare, leadership, and culture. In the inaugural edition, Travis talks with Nueterra Capital Chairman Dan Tasset about living and working with purpose.
Leawood, KS – May 18, 2018 – The Chairman of Nueterra Capital would like to announce the hiring of Scott C. Palecki as General Counsel and Ms. Alex Knudson as Legal Project Manager for Nueterra Capital and its affiliates and subsidiaries which include ValueHealth, NueHealth, Muve Health, the ValueHealth Transformation Center, Healthcare RE, ValueHealth Specialty Group, and Benefit Management.
Palecki is a veteran healthcare attorney with over 20 years of proven and steadfast private practice experience. Scott has participated in hundreds of healthcare and corporate transactions including the development, management and syndication of over 100 hospitals and ambulatory surgical centers throughout the United States.
“We are very fortunate Mr. Palecki has joined the Nueterra team. He brings vast experience in business and healthcare, and his knowledge and leadership will be invaluable in helping us achieve our mission of implementing value-based care to the United States healthcare delivery system,” said Chairman Daniel R. Tasset. “We admire his success in facing difficult adversaries, tackling tough issues, and achieving changes in healthcare.”
Knudson has 15 years of executive business and project management experience in the legal healthcare field, real estate, land development, and finance industries. Alex has participated in numerous contract negotiations, managed a land portfolio of several hundred acres in excess of $165 million and delivered new projects across targeted markets.
“We are excited to add Ms. Knudson to our team. Her proven and diligent track record of analytics, project management and tenacity will help keep us on target to achieve our sizable goals to implement value-based care to the United States healthcare delivery system,” said Chairman Daniel R. Tasset.
About Nueterra Capital
Nueterra Capital is a private equity investment and advisory firm with an exclusive focus on healthcare. Leveraging a deep understanding of key industry drivers, Nueterra Capital invests in entrepreneurs with innovative minds, while providing professional expertise and back office resources to improve their bottom line performance and drive growth. Nueterra Capital has invested in hundreds of new ventures and continuously delivers the resources and strategic direction that allow our partners to advance and improve every aspect of healthcare.